About Cerveau Technologies
Cerveau Technologies is a Healthcare company based in Boston (United States) founded in 2015, and was acquired by Lantheus in February 2023. Research collaborations and global strategies are employed for product development. Cerveau Technologies offers products and services including MK-6240. Its focus areas include Biopharma Outsourcing, Consulting and Clinical Development. Its competitors include Blue Matter Consulting and MCRA.
Company details
Founded in 2015 in Boston, United States, Cerveau Technologies is involved in research on early-stage imaging agents, radiopharmaceuticals, and neurodegenerative diseases. Global commercial strategies and student exchange programs are offered to support clinical development. Agreements with universities and industries, including Siemens Healthineers, Merck, Biogen, McGill University, and Austin Health, are upheld for publishable data generation and manufacturing of positron emission tomography tools.
- Headquarters Boston, United States
- Stage Acquired
- SectorsHealthcare
- Website cerveautechnologies.com
- Social X
- Acquired by Lantheus (Feb 2023)
Products & Services of Cerveau Technologies
Cerveau Technologies offers a comprehensive portfolio of products and services, including MK-6240.
Investigational tracer for detecting tau tangles in Alzheimer's disease.
Investors in Cerveau Technologies
Cerveau Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Lantheus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developer of diagnostic imaging agents and targeted therapeutics | 2008 | lantheus.com | Billerica, United States |
Investor details for Cerveau Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cerveau Technologies
21 people are tracked at Cerveau Technologies (4 in leadership, 13 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Rick Hiatt | President & CEO | Leadership |
Dave Casebier | VP, Technical Operations | Leadership |
Joanna Shuping | Head of Clinical Operations | Leadership |
Bill Abbott | VP, Commercialization | Leadership |
Dave Smith | Senior Planning Advisor | Board & advisors |
John Doumitt | Senior Planning Advisor | Board & advisors |
Mas Tsuno | Special Advisor | Board & advisors |
Chase Dearborn | Senior Legal Advisor | Board & advisors |
Serge Gauthier | Scientific Advisor | Board & advisors |
Jeffrey L. Evelhoch | Scientific Advisor | Board & advisors |
Kenji Ishii | Scientific Advisor | Board & advisors |
Koen Van Laere | Scientific Advisor | Board & advisors |
Christopher Rowe | Scientific Advisor | Board & advisors |
Eric M Reiman | Scientific Advisor | Board & advisors |
Keith Johnson | Scientific Advisor | Board & advisors |
Oskar Hansson | Scientific Advisor | Board & advisors |
Richard Hargreaves | Scientific Advisor | Board & advisors |
David Morehous | General Counsel | Team |
Sulantha Mathotaarachchi | Solutions Architect, Neuroinformatics | Team |
Thom Tulip | Senior Advisor | Team |
1 more people are available in the full profile.
Complete people profiles for Cerveau Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cerveau Technologies
2 dated milestones of Cerveau Technologies across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Cerveau Technologies is founded.
- Exit Acquired by Lantheus.
Competitors of Cerveau Technologies
Cerveau Technologies has 2 listed competitors in our database. They include Blue Matter Consulting and MCRA.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bluematterconsulting.com | 2012 | San Francisco, United States | 98 | Provider of consulting services focused for clinical drug development | ||
| mcra.com | 2004 | New York, United States | Provider of regulatory, quality assurance and market access services to biopharma sector |
Detailed competitors of Cerveau Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cerveau Technologies
The website of Cerveau Technologies (cerveautechnologies.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 9.8% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Cerveau Technologies (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cerveau Technologies
Complete news archive for Cerveau Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cerveau Technologies
Cerveau Technologies was founded in 2015.
Cerveau Technologies is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Founded in 2015 in Boston, United States, Cerveau Technologies is involved in research on early-stage imaging agents, radiopharmaceuticals, and neurodegenerative diseases. Global commercial strategies and student exchange programs are offered to support clinical development. Agreements with universities and industries, including Siemens Healthineers, Merck, Biogen, McGill University, and Austin Health, are upheld for publishable data generation and manufacturing of positron emission tomography tools.
Cerveau Technologies's top competitors include Blue Matter Consulting and MCRA.
Cerveau Technologies offers MK-6240.
Cerveau Technologies has 1 investor. Key investors include Lantheus.
Yes. Cerveau Technologies was acquired by Lantheus in February 2023.